Putnam Investments LLC Astrazeneca PLC Transaction History

Putnam Investments LLC

$73 Billion
Q4 2023

A detailed history of Putnam Investments LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Putnam Investments LLC holds 7,729,834 shares of AZN stock, worth $582 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

7,729,834

Previous 7,396,524 4.51%

Holding current value

$582 Million

Previous $501 Million 3.94%

% of portfolio

0.71%

Previous 0.79%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $20.6 Million - $23.1 Million	333,310 Added 4.51%	7,729,834 $521 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $7.82 Million - $8.65 Million	-120,576 Reduced 1.6%	7,396,524 $501 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $3.46 Million - $3.76 Million	49,534 Added 0.66%	7,517,100 $538 Million
Q1 2023 May 22, 2023	BUY	$63.15 - $71.6 $1.58 Million - $1.79 Million	25,033 Added 0.34%	7,467,566 $518 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $5.52 Million - $7.18 Million	101,862 Added 1.39%	7,442,533 $505 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $115,901 - $296,749	-2,186 Reduced 0.03%	7,340,671 $403 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $1.62 Million - $1.94 Million	27,295 Added 0.37%	7,342,857 $485 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $10.9 Million - $13.2 Million	196,259 Added 2.76%	7,315,562 $485 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $3.08 Million - $3.64 Million	57,031 Added 0.81%	7,119,303 $415 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $131 Million - $143 Million	2,354,345 Added 50.01%	7,062,272 $424 Million
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $634,108 - $788,117	13,096 Added 0.28%	4,707,927 $282 Million
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $9.99 Million - $11.5 Million	211,857 Added 4.73%	4,694,831 $233 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $12.2 Million - $14.6 Million	251,641 Added 5.95%	4,482,974 $224 Million
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $1.84 Million - $2.12 Million	34,723 Added 0.83%	4,231,333 $232 Million
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $24.9 Million - $31.9 Million	-577,255 Reduced 12.09%	4,196,610 $222 Million
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $3 Million - $4.08 Million	79,498 Added 1.69%	4,773,865 $213 Million
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $2.2 Million - $2.62 Million	51,880 Added 1.12%	4,694,367 $234 Million
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $2.23 Million - $2.53 Million	55,706 Added 1.21%	4,642,487 $207 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $172,345 - $192,686	4,623 Added 0.1%	4,586,781 $189 Million
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $2.03 Million - $2.46 Million	57,272 Added 1.27%	4,582,158 $185 Million
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $4.19 Million - $4.72 Million	113,734 Added 2.58%	4,524,886 $172 Million
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $934,522 - $1.07 Million	26,885 Added 0.61%	4,411,152 $175 Million
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $355,692 - $381,429	-10,295 Reduced 0.23%	4,384,267 $154 Million
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $92,085 - $102,307	-2,793 Reduced 0.06%	4,394,562 $154 Million
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $2.13 Million - $2.31 Million	66,300 Added 1.53%	4,397,355 $153 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $125 Million - $147 Million	4,331,055	4,331,055 $147 Million

Others Institutions Holding AZN

# of Institutions

1,413

Shares Held

506M

Call Options Held

9.17M

Put Options Held

3.07M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $233B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Account

Putnam Investments LLC Astrazeneca PLC Transaction History